The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2006

Filed:

Nov. 18, 2000
Applicants:

John E. Edwards, Jr., Palos Verdes, CA (US);

Scott G. Filler, Rancho Palos Verdes, CA (US);

Donald C. Sheppard, Montreal, CA;

Ashraf S. Ibrahim, La Mirada, CA (US);

Yue Fu, Torrance, CA (US);

Bradley J. Spellberg, Ranchos Palos Verdes, CA (US);

Inventors:

John E. Edwards, Jr., Palos Verdes, CA (US);

Scott G. Filler, Rancho Palos Verdes, CA (US);

Donald C. Sheppard, Montreal, CA;

Ashraf S. Ibrahim, La Mirada, CA (US);

Yue Fu, Torrance, CA (US);

Bradley J. Spellberg, Ranchos Palos Verdes, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/00 (2006.01); C07K 1/00 (2006.01); C07K 2/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Abloodstream infections cause significant morbidity and mortality in hospitalized patients. Filament formation and adherence to host cells are critical virulence factors of. Multiple filamentation regulatory pathways have been discovered, however the downstream effectors of these regulatory pathways remain unknown. The cell surface protein, Als1p, is a downstream effector of the filamentation regulatory pathway and is regulated by Efg1p. Als1p mediates adherence to endothelial cells in vitro and is required for virulence. The blocking of adherence by the organism is described resulting from the use of a composition and method disclosed herein. Specifically, a pharmaceutical composition comprised of a gene product from the ALS1 gene family is administered as a vaccine to generate an immune response capable of blocking adherence of the organism.


Find Patent Forward Citations

Loading…